218 related articles for article (PubMed ID: 38558130)
1. Exploring Ferroptosis-Inducing Therapies for Cancer Treatment: Challenges and Opportunities.
Lei G; Gan B
Cancer Res; 2024 Apr; 84(7):961-964. PubMed ID: 38558130
[TBL] [Abstract][Full Text] [Related]
2. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.
Lei G; Zhuang L; Gan B
Cancer Cell; 2024 Apr; 42(4):513-534. PubMed ID: 38593779
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
Zhou Q; Meng Y; Li D; Yao L; Le J; Liu Y; Sun Y; Zeng F; Chen X; Deng G
Signal Transduct Target Ther; 2024 Mar; 9(1):55. PubMed ID: 38453898
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response.
Yao Y; Shi Y; Gao Z; Sun Y; Yao F; Ma L
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C95-C103. PubMed ID: 35613358
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis in life: To be or not to be.
Xu L; Liu Y; Chen X; Zhong H; Wang Y
Biomed Pharmacother; 2023 Mar; 159():114241. PubMed ID: 36634587
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-Dependent Ferroptosis as a Therapeutic Target in Cancer.
Liu L; Li L; Li M; Luo Z
ChemMedChem; 2021 Oct; 16(19):2942-2950. PubMed ID: 34110079
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis: A Trusted Ally in Combating Drug Resistance in Cancer.
Ozkan E; Bakar-Ates F
Curr Med Chem; 2022; 29(1):41-55. PubMed ID: 34375173
[TBL] [Abstract][Full Text] [Related]
9. Metabolic regulation of ferroptosis in the tumor microenvironment.
Mbah NE; Lyssiotis CA
J Biol Chem; 2022 Mar; 298(3):101617. PubMed ID: 35065965
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis in colorectal cancer: a future target?
Yan H; Talty R; Aladelokun O; Bosenberg M; Johnson CH
Br J Cancer; 2023 Apr; 128(8):1439-1451. PubMed ID: 36703079
[TBL] [Abstract][Full Text] [Related]
11. Targeting ferroptosis as a vulnerability in cancer.
Lei G; Zhuang L; Gan B
Nat Rev Cancer; 2022 Jul; 22(7):381-396. PubMed ID: 35338310
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
Zhu L; Meng D; Wang X; Chen X
ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
[TBL] [Abstract][Full Text] [Related]
13. Induction of ferroptosis by natural phenols: A promising strategy for cancer therapy.
Zhang Y; Xie J
Phytother Res; 2024 Apr; 38(4):2041-2076. PubMed ID: 38391022
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer.
Shi TM; Chen XF; Ti H
J Med Chem; 2024 Feb; 67(4):2238-2263. PubMed ID: 38306267
[TBL] [Abstract][Full Text] [Related]
15. Parallel Lipid Peroxide Accumulation Strategy Based on Bimetal-Organic Frameworks for Enhanced Ferrotherapy.
Xin H; Wang F; Luo R; Lei J
Chemistry; 2021 Mar; 27(13):4307-4311. PubMed ID: 33377225
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Targeting of Ferroptosis in Cancer Treatment.
Valashedi MR; Nikoo A; Najafi-Ghalehlou N; Tomita K; Kuwahara Y; Sato T; Roushandeh AM; Roudkenar MH
Curr Cancer Drug Targets; 2022; 22(2):108-125. PubMed ID: 34856903
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
Liu N; Chen M
Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
[TBL] [Abstract][Full Text] [Related]
18. A guide to ferroptosis in cancer.
Yapici FI; Bebber CM; von Karstedt S
Mol Oncol; 2024 Jun; 18(6):1378-1396. PubMed ID: 38590214
[TBL] [Abstract][Full Text] [Related]
19. Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy.
Xiang D; Zhou L; Yang R; Yuan F; Xu Y; Yang Y; Qiao Y; Li X
Int J Nanomedicine; 2024; 19():2091-2112. PubMed ID: 38476278
[TBL] [Abstract][Full Text] [Related]
20. Free docosahexaenoic acid promotes ferroptotic cell death via lipoxygenase dependent and independent pathways in cancer cells.
Shan K; Feng N; Zhu D; Qu H; Fu G; Li J; Cui J; Chen H; Wang R; Qi Y; Chen YQ
Eur J Nutr; 2022 Dec; 61(8):4059-4075. PubMed ID: 35804267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
